Literature DB >> 15555602

Effects of non-steroid anti-inflammatory drugs in membrane bilayers.

I Kyrikou1, S K Hadjikakou, D Kovala-Demertzi, K Viras, T Mavromoustakos.   

Abstract

The thermal effects of non-steroidal anti-inflammatory drugs (NSAIDs) meloxicam, tenoxicam, piroxicam and lornoxicam have been studied in dipalmitoylphosphatidylcholine (DPPC) membrane bilayers using neutral and acidic environments (pH 2.5). The strength of the perturbing effect of the drugs is summarized to a lowering of the main phase transition temperature and a broadening of the phase transition temperature as well as broadening or abolishment of the pretransition of DPPC bilayers. The thermal profiles in the two environments were very similar. Among the NSAIDs studied meloxicam showed the least perturbing effect. The differential scanning calorimetry results (DSC) in combination with molecular modeling studies point out that NSAIDs are characterized by amphoteric interactions and are extended between the polar and hydrophobic segments of lipid bilayers. The effects of NSAIDs in membrane bilayers were also investigated using Raman spectroscopy. Meloxicam showed a gauche:trans profile similar to DPPC bilayers while the other NSAIDs increased significantly the gauche:trans ratio. In conclusion, both techniques show that in spite of the close structural similarity of the NSAIDs studied, meloxicam appears to have the lowest membrane perturbing effects probably attributed to its highest lipophilicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555602     DOI: 10.1016/j.chemphyslip.2004.06.005

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  7 in total

1.  Comparison of thermal effects of stilbenoid analogs in lipid bilayers using differential scanning calorimetry and molecular dynamics: correlation of thermal effects and topographical position with antioxidant activity.

Authors:  Catherine Koukoulitsa; Serdar Durdagi; Eleni Siapi; Carolina Villalonga-Barber; Xanthippi Alexi; Barry R Steele; Maria Micha-Screttas; Michael N Alexis; Anna Tsantili-Kakoulidou; Thomas Mavromoustakos
Journal:  Eur Biophys J       Date:  2011-05-08       Impact factor: 1.733

2.  Interaction of salicylate and a terpenoid plant extract with model membranes: reconciling experiments and simulations.

Authors:  Himanshu Khandelia; Sarah Witzke; Ole G Mouritsen
Journal:  Biophys J       Date:  2010-12-15       Impact factor: 4.033

3.  Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.

Authors:  Lenard M Lichtenberger; Yong Zhou; Vasanthi Jayaraman; Janice R Doyen; Roger G O'Neil; Elizabeth J Dial; David E Volk; David G Gorenstein; Mohan Babu Boggara; Ramanan Krishnamoorti
Journal:  Biochim Biophys Acta       Date:  2012-04-14

4.  Isolation of Lipid Rafts by the Detergent-Based and Non-detergent-Based Methods for Localization of GPCRs with Immunoblotting and Laser Scanning Confocal Microscopy.

Authors:  Peter Abdelmaseeh; Andrew C Tiu; Selim Rozyyev; Laureano D Asico; Pedro A Jose; Van Anthony M Villar
Journal:  Methods Mol Biol       Date:  2021

5.  Interaction of Oxicam Derivatives with the Artificial Models of Biological Membranes-Calorimetric and Fluorescence Spectroscopic Study.

Authors:  Jadwiga Maniewska; Żaneta Czyżnikowska; Berenika M Szczęśniak-Sięga; Krystyna Michalak
Journal:  Membranes (Basel)       Date:  2022-08-17

6.  A Molecular Biophysical Approach to Diclofenac Topical Gastrointestinal Damage.

Authors:  Eduarda Fernandes; Telma B Soares; Hugo Gonçalves; Sigrid Bernstorff; Maria Elisabete C D Real Oliveira; Carla M Lopes; Marlene Lúcio
Journal:  Int J Mol Sci       Date:  2018-10-31       Impact factor: 5.923

7.  Assessment of Lipophilicity Descriptors of Selected NSAIDs Obtained at Different TLC Stationary Phases.

Authors:  Małgorzata Starek; Alina Plenis; Marta Zagrobelna; Monika Dąbrowska
Journal:  Pharmaceutics       Date:  2021-03-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.